Eckert & Ziegler Strahlen- und Medizintechnik AG

Board/Management Information • Dec 9, 2004

News Details

Corporate | 9 December 2004 10:10

Eckert & Ziegler AG expands Supervisory Board

Corporate-news announcement sent by DGAP. The sender is solely responsible for the contents of this announcement. ——————————————————————————– Eckert & Ziegler AG expands Supervisory Board / Successful delivery of large-scale production facility Berlin, 9 December 2004. The Supervisory Board of Eckert & Ziegler AG (ISIN DE0005659700) has appointed Dr. Andreas Hey (45), a physician, as the third member of the company’s Supervisory Board, effective as of 1 January 2005. He will be responsible for the Industry & Nuclear Imaging segment, and thus the part of the Pankow-based medical technology company that has thus far generated slightly more than half of Group sales. The Therapy segment, which has shown a strong increase in sales recently and whose products are designed primarily for radiation therapy, will continue to be led by medical physicist Dr. Edgar Löffler. Dr. Hey previously held the position of managing director of Isotope Products Europe in Waldburg (Baden-Württemberg), a subsidiary of Eckert & Ziegler AG which recently switched from majority-held to wholly-owned status. Before that, he worked as managing director of NEMOD Biotherapeutics GmbH & Co. KG and as an investment manager, independent consultant, and product manager for a number of companies in the life sciences sector. Successful delivery Coinciding with the end of the year, and considerably before the planned delivery date, Eckert & Ziegler subsidiary EUROTOPE Entwicklungsgesellschaft für Isotopentechnologien mbH has now delivered its second large-scale facility to the USA at a value of over one million USD. Following comprehensive trial runs, this production cell for a therapeutic radioactive component was accepted by the customer on-site with no reservations. Your contact for inquiries: Eckert & Ziegler AG, Karolin Riehle, Investor Relations Robert-Rössle-Str. 10, D-13125 Berlin phone: +49 (0) 30 / 94 10 84-138 http://www.ezag.de end of message, (c)DGAP 09.12.2004 ——————————————————————————– WKN: 565970; ISIN: DE0005659700; Index: Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover und Stuttgart 091010 Dez 04